00012807842023FYfalsehttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2023#RealizedInvestmentGainsLosseshttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2023#RealizedInvestmentGainsLosseshttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent0200.3333.3333.333300012807842023-01-012023-12-310001280784htgc:CommonStockParValueZeroPointZeroZeroOnePerShareMember2023-01-012023-12-310001280784htgc:SixPointTwoFiveNotesDueTwoThousandThirtyThreeMember2023-01-012023-12-3100012807842023-06-30iso4217:USD00012807842024-02-08xbrli:shares0001280784htgc:WeOperateInAHighlyCompetitiveMarketForInvestmentOpportunitiesMember2023-01-012023-12-310001280784htgc:WeAreDependentUponSeniorManagementPersonnelForOurFutureSuccessParticularlyScottBluesteinMember2023-01-012023-12-310001280784htgc:OurSuccessDependsOnAttractingAndRetainingQualifiedPersonnelInACompetitiveEnvironmentMember2023-01-012023-12-310001280784htgc:AsAnInternallyManagedBdcWeAreSubjectToCertainRestrictionsThatMayAdverselyAffectOurBusinessMember2023-01-012023-12-310001280784htgc:OurBusinessModelDependsToASignificantExtentUponStrongReferralRelationshipsMember2023-01-012023-12-310001280784htgc:OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrStockholderApprovalTheEffectsOfWhichMayBeAdverseMember2023-01-012023-12-310001280784htgc:WeMayNotBeAbleToPayDistributionsToStockholdersDistributionsMayNotGrowOverTimeAndAPortionOfDistributionsPaidToStockholdersMayBeAReturnOfCapitalWhichIsADistributionOfTheStockholdersInvestedCapitalMember2023-01-012023-12-310001280784htgc:WeAreSubjectToRisksRelatedToCorporateSocialResponsibilityMember2023-01-012023-12-310001280784htgc:OurInvestmentsInPortfolioCompaniesInvolveHigherLevelsOfRiskAndWeCouldLoseAllOrPartOfOurInvestmentMember2023-01-012023-12-310001280784htgc:ALackOfIpoOrMergerAndAcquisitionOpportunitiesMayCauseCompaniesToStayInOurPortfolioLongerLeadingToLowerReturnsUnrealizedDepreciationOrRealizedLossesMember2023-01-012023-12-310001280784htgc:InvestingInPubliclyTradedCompaniesCanInvolveAHighDegreeOfRiskAndCanBeSpeculativeMember2023-01-012023-12-310001280784htgc:OurInvestmentsAreConcentratedInCertainTechnologyRelatedIndustriesWhichSubjectsUsToTheRiskOfSignificantLossIfAnyOneOrMoreOfSuchIndustriesExperiencesADownturnMember2023-01-012023-12-310001280784htgc:OurFinancialResultsCouldBeNegativelyAffectedIfASignificantPortfolioInvestmentFailsToPerformAsExpectedMember2023-01-012023-12-310001280784htgc:WeMayBeExposedToHigherRisksWithRespectToOurInvestmentsThatIncludePikInterestOrExitFeesMember2023-01-012023-12-310001280784htgc:TheLackOfLiquidityInOurInvestmentsMayAdverselyAffectOurBusinessMember2023-01-012023-12-310001280784htgc:WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesMember2023-01-012023-12-310001280784htgc:ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember2023-01-012023-12-310001280784htgc:WeAreANonDiversifiedInvestmentCompanyWithinTheMeaningOfThe1940ActAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember2023-01-012023-12-310001280784htgc:WeGenerallyWillNotControlOurPortfolioCompaniesMember2023-01-012023-12-310001280784htgc:DefaultsByOurPortfolioCompaniesWillHarmOurOperatingResultsMember2023-01-012023-12-310001280784htgc:SubstantiallyAllOfOurPortfolioInvestmentsAreRecordedAtFairValueAsDeterminedInAccordanceWithOurValuationGuidelinesAndAsAResultThereMayBeUncertaintyAsToTheValueOfOurPortfolioInvestmentsMember2023-01-012023-12-310001280784htgc:AnyUnrealizedDepreciationWeExperienceOnInvestmentPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionAndCouldImpairOurAbilityToServiceOurBorrowingsMember2023-01-012023-12-310001280784htgc:PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember2023-01-012023-12-310001280784htgc:ThePhaseOutAndReplacementOfLIBORMayAdverselyAffectTheValueOfOurPortfolioSecuritiesMember2023-01-012023-12-310001280784htgc:WeAreSubjectToRisksAssociatedWithTheCurrentInterestRateEnvironmentAndChangesInInterestRatesWillAffectOurCostOfCapitalNetInvestmentIncomeAndTheValueOfOurInvestmentsMember2023-01-012023-12-310001280784htgc:WeMayNotRealizeGainsFromOurEquityOrWarrantInvestmentsMember2023-01-012023-12-310001280784htgc:WeMayExposeOurselvesToRisksIfWeEngageInHedgingTransactionsMember2023-01-012023-12-310001280784htgc:OurInvestmentsInForeignSecuritiesOrInvestmentsDenominatedInForeignCurrenciesMayInvolveSignificantRisksInAdditionToTheRisksInherentInUSAndUSDenominatedInvestmentsMember2023-01-012023-12-310001280784htgc:TheDispositionOfOurInvestmentsMayResultInContingentLiabilitiesMember2023-01-012023-12-310001280784htgc:DependingOnFundingRequirementsWeMayNeedToRaiseAdditionalCapitalToMeetOurUnfundedCommitmentsThroughAdditionalBorrowingsMember2023-01-012023-12-310001280784htgc:BecauseWeHaveSubstantialBorrowingsThePotentialForGainOrLossOnAmountsInvestedInUsIsMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember2023-01-012023-12-31xbrli:pure0001280784htgc:CertainOfOurAssetsAreSubjectToSecurityInterestsUnderOurSeniorSecuritiesAndIfWeDefaultOnOurObligationsUnderOurSeniorSecuritiesWeMaySufferAdverseConsequencesIncludingForeclosureOnThoseAssetsMember2023-01-012023-12-310001280784htgc:OurExecutiveOfficersAndEmployeesThroughTheAdviserSubsidiaryAreExpectedToManageTheAdviserFundsOrSeparatelyManagedAccountsMember2023-01-012023-12-310001280784htgc:InvestmentsInTheAdviserFundsManagedByOurAdviserSubsidiaryMayCreateConflictsOfInterestsMember2023-01-012023-12-310001280784htgc:WeThroughTheAdviserSubsidiaryDeriveRevenuesFromManagingThirdPartyFundsPursuantToManagementAgreementsThatMayBeTerminatedMember2023-01-012023-12-310001280784htgc:FailureToComplyWithApplicableLawsOrRegulationsAndChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember2023-01-012023-12-310001280784htgc:FailureToMaintainOurStatusAsABdcWouldReduceOurOperatingFlexibilityMember2023-01-012023-12-310001280784htgc:OperatingUnderTheConstraintsImposedOnUsAsABdcAndRicMayHinderTheAchievementOfOurInvestmentObjectivesMember2023-01-012023-12-310001280784htgc:RegulationsGoverningOurOperationAsABdcWillAffectOurAbilityToAndTheWayInWhichWeRaiseAdditionalCapitalMember2023-01-012023-12-310001280784htgc:InvestingInOurSecuritiesMayInvolveAHighDegreeOfRiskMember2023-01-012023-12-310001280784htgc:SharesOfClosedEndInvestmentCompaniesIncludingBdcsMayTradeAtADiscountToTheirNavMember2023-01-012023-12-310001280784htgc:TheMarketPriceOfOurSecuritiesMayBeVolatileAndFluctuateSignificantlyMember2023-01-012023-12-310001280784htgc:StockholdersMayIncurDilutionIfWeSellSharesOfCommonStockInOneOrMoreOfferingsAtPricesBelowThenCurrentNavPerShareOfCommonStockOrIssueSecuritiesToSubscribeToConvertToOrPurchaseSharesOfOurCommonStockMember2023-01-012023-12-310001280784htgc:ProvisionsOfTheMarylandGeneralCorporationLawAndOfOurCharterAndBylawsCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnThePriceOfOurCommonStockMember2023-01-012023-12-310001280784htgc:WeMayInTheFutureDetermineToIssuePreferredStockWhichCouldAdverselyAffectTheMarketValueOfOurCommonStockMember2023-01-012023-12-310001280784htgc:TheNotesAreUnsecuredAndThereforeEffectivelySubordinatedToAnyCurrentOrFutureSecuredIndebtednessMember2023-01-012023-12-310001280784htgc:TheNotesAreStructurallySubordinatedToTheIndebtednessAndOtherLiabilitiesOfOurSubsidiariesMember2023-01-012023-12-310001280784htgc:TheNotesMayOrMayNotHaveAnEstablishedTradingMarketIfATradingMarketInTheNotesIsDevelopedItMayNotBeMaintainedMember2023-01-012023-12-310001280784htgc:ADowngradeSuspensionOrWithdrawalOfTheCreditRatingAssignedByARatingAgencyToUsOrOurDebtSecuritiesMember2023-01-012023-12-310001280784htgc:TheRespectiveIndenturesUnderWhichTheNotesWereIssuedContainLimitedProtectionsForTheHoldersOfTheNotesMember2023-01-012023-12-310001280784htgc:TermsRelatingToRedemptionMayMateriallyAdverselyAffectYourReturnOnAnyDebtSecuritiesThatWeMayIssueMember2023-01-012023-12-310001280784htgc:IfWeDefaultOnOurObligationsImposedUponUsByOurIndebtednessWeMayNotBeAbleToMakePaymentsOnOurOutstandingNotesAndCreditFacilitiesMember2023-01-012023-12-310001280784htgc:WeMayNotBeAbleToPrepayTheNotesOrCreditFacilitiesUponAChangeInControlMember2023-01-012023-12-310001280784htgc:AnyInabilityToRenewExtendOrReplaceOurCreditFacilitiesCouldAdverselyImpactOurLiquidityAndAbilityToFindNewInvestmentsOrMaintainDistributionsToOurStockholdersMember2023-01-012023-12-310001280784htgc:WeThroughOurWhollyOwnedSubsidiaryIssueDebtSecuritiesGuaranteedByTheSbaAndSoldInTheCapitalMarketsMember2023-01-012023-12-310001280784htgc:OurWhollyOwnedSubsidiaryIsLicensedByTheSbaAndThereforeSubjectToSbicRegulationsMember2023-01-012023-12-310001280784htgc:OurSbicSubsidiaryMayBeUnableToMakeDistributionsToUsThatWillEnableUsToMeetOrMaintainRicStatusWhichCouldResultInTheImpositionOfAnEntityLevelTaxMember2023-01-012023-12-310001280784htgc:WeWillBeSubjectToUSFederalIncomeTaxIfWeAreUnableToQualifyAsARicUnderSubchapterMOfTheCodeMember2023-01-012023-12-310001280784htgc:WeMayHaveDifficultyPayingTheDistributionsRequiredToMaintainRicStatusUnderTheCodeIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember2023-01-012023-12-310001280784htgc:WeMayInTheFutureChooseToPayDistributionsInOurOwnStockInWhichCaseYouMayBeRequiredToPayTaxInExcessOfTheCashYouReceiveMember2023-01-012023-12-310001280784htgc:StockholdersMayHaveCurrentTaxLiabilityOnDividendsTheyElectToReinvestInOurCommonStockButWouldNotReceiveCashFromSuchDividendsToPaySuchTaxLiabilityMember2023-01-012023-12-310001280784htgc:LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectOurStockholdersMember2023-01-012023-12-310001280784htgc:FatcaWithholdingMayApplyToPaymentsMadeToCertainForeignEntitiesMember2023-01-012023-12-310001280784htgc:WeAreCurrentlyOperatingInAPeriodOfCapitalMarketsDisruptionAndEconomicUncertaintyAndCapitalMarketsMayExperiencePeriodsOfDisruptionAndInstabilityInTheFutureMember2023-01-012023-12-310001280784htgc:DeteriorationInTheEconomyAndFinancialMarketsCouldImpairOurPortfolioCompaniesFinancialPositionsAndOperatingResultsAndAffectTheIndustriesInWhichWeInvestWhichCouldInTurnHarmOurOperatingResultsMember2023-01-012023-12-310001280784htgc:WeMayExperienceFluctuationsInOurOperatingResultsMember2023-01-012023-12-310001280784htgc:TerroristAttacksActsOfWarPublicHealthCrisesClimateChangeOrNaturalDisastersMayAffectAnyMarketForOurSecuritiesImpactTheBusinessesInWhichWeInvestAndHarmOurBusinessMember2023-01-012023-12-310001280784htgc:TechnologicalInnovationsAndIndustryDisruptionsIncludingThoseRelatedToArtificialIntelligenceAndMachineLearningMayNegativelyImpactUsMember2023-01-012023-12-310001280784htgc:WeAreHighlyDependentOnInformationSystemsAndSystemsFailuresCouldSignificantlyDisruptOurBusinessWhichMayInTurnNegativelyAffectTheMarketPriceOfOurCommonStockAndOurAbilityToPayDividendsMember2023-01-012023-12-310001280784htgc:FailureInCyberSecuritySystemsAsWellAsTheOccurrenceOfEventsUnanticipatedInOurDisasterRecoverySystemsAndBusinessContinuityPlanningCouldImpairOurAbilityToConductBusinessMember2023-01-012023-12-310001280784htgc:WeMayExperienceFluctuationsInOurQuarterlyOperatingResultsMember2023-01-012023-12-310001280784htgc:WeMayBeTheTargetOfLitigationMember2023-01-012023-12-3100012807842021-03-31iso4217:USDxbrli:shares00012807842021-01-012021-03-3100012807842021-06-3000012807842021-04-012021-06-3000012807842021-09-3000012807842021-07-012021-09-3000012807842021-12-3100012807842021-10-012021-12-3100012807842022-03-3100012807842022-01-012022-03-3100012807842022-06-3000012807842022-04-012022-06-3000012807842022-09-3000012807842022-07-012022-09-3000012807842022-12-3100012807842022-10-012022-12-3100012807842023-03-3100012807842023-01-012023-03-3100012807842023-04-012023-06-3000012807842023-09-3000012807842023-07-012023-09-3000012807842023-12-3100012807842023-10-012023-12-310001280784us-gaap:InvestmentUnaffiliatedIssuerMember2023-12-310001280784us-gaap:InvestmentUnaffiliatedIssuerMember2022-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2023-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2022-12-310001280784us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310001280784us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-310001280784us-gaap:InvestmentUnaffiliatedIssuerMember2023-01-012023-12-310001280784us-gaap:InvestmentUnaffiliatedIssuerMember2022-01-012022-12-310001280784us-gaap:InvestmentUnaffiliatedIssuerMember2021-01-012021-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2023-01-012023-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2022-01-012022-12-310001280784us-gaap:InvestmentAffiliatedIssuerControlledMember2021-01-012021-12-310001280784us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2023-01-012023-12-310001280784us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2022-01-012022-12-310001280784us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2021-01-012021-12-3100012807842022-01-012022-12-3100012807842021-01-012021-12-310001280784us-gaap:CommonStockMember2020-12-310001280784htgc:CapitalInExcessOfParValueMember2020-12-310001280784htgc:DistributableEarningsLossMember2020-12-3100012807842020-12-310001280784htgc:DistributableEarningsLossMember2021-01-012021-12-310001280784us-gaap:CommonStockMember2021-01-012021-12-310001280784htgc:CapitalInExcessOfParValueMember2021-01-012021-12-310001280784us-gaap:CommonStockMember2021-12-310001280784htgc:CapitalInExcessOfParValueMember2021-12-310001280784htgc:DistributableEarningsLossMember2021-12-310001280784htgc:DistributableEarningsLossMember2022-01-012022-12-310001280784us-gaap:CommonStockMember2022-01-012022-12-310001280784htgc:CapitalInExcessOfParValueMember2022-01-012022-12-310001280784us-gaap:CommonStockMember2022-12-310001280784htgc:CapitalInExcessOfParValueMember2022-12-310001280784htgc:DistributableEarningsLossMember2022-12-310001280784htgc:DistributableEarningsLossMember2023-01-012023-12-310001280784us-gaap:CommonStockMember2023-01-012023-12-310001280784htgc:CapitalInExcessOfParValueMember2023-01-012023-12-310001280784us-gaap:CommonStockMember2023-12-310001280784htgc:CapitalInExcessOfParValueMember2023-12-310001280784htgc:DistributableEarningsLossMember2023-12-310001280784Debt Investments Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee2023-12-310001280784Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee2023-12-310001280784Debt Investments Biotechnology Tools (2.66%)2023-12-310001280784Debt Investments Biotechnology Tools (2.02%)2023-12-310001280784Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee2023-12-310001280784Debt Investments Communications and Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62%2023-12-310001280784Debt Investments Subtotal: Communications & Networking (1.62%)2023-12-310001280784Debt Investments Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee2023-12-31iso4217:GBP0001280784Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50%2023-12-310001280784Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 3.00% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%2023-12-310001280784Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26%2023-12-310001280784Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%2023-12-310001280784Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Seat Geek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Total SeatGeek, Inc., Senior Secured2023-12-310001280784Debt Investments Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25%2023-12-310001280784Debt Investments Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Total Veem, Inc.2023-12-310001280784Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee2023-12-310001280784Debt Investments Consumer & Business Services and Total Worldremit Group Limited2023-12-310001280784Debt Investments Consumer & Business Services (28.24%)2023-12-310001280784Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50%2023-12-310001280784Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, FIXED + 11.95%2023-12-310001280784Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC)2023-12-310001280784Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%2023-12-310001280784Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50%2023-12-310001280784Debt Investments Diversified Financial Services (3.17%)2023-12-310001280784Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and HilleVax, Inc., Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2026, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, Maturity Date December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee2023-12-310001280784Debt Investments Drug Discovery & Development (66.60%)2023-12-310001280784Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee2023-12-310001280784Debt Investments Electronics & Computer Hardware (1.05%)2023-12-310001280784Debt Investments Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45%2023-12-310001280784Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%2023-12-310001280784Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee2023-12-310001280784srt:MinimumMemberDebt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee2023-12-310001280784Debt Investments Healthcare Services, Other (16.56%)2023-12-310001280784Debt Investments Information Services and Capella Space Corp., Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee2023-12-310001280784Debt Investments Information Services and Checkr Group, Inc., Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee2023-12-310001280784Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee2023-12-310001280784Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee2023-12-310001280784Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.45%, Floor rate 9.35%2023-12-310001280784Debt Investments Information Services (6.65%)2023-12-310001280784Debt Investments Manufacturing Technology and Bright Machines, Inc., Senior Secured, Maturity Date May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee2023-12-310001280784Debt Investments Manufacturing Technology (0.44%)2023-12-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee2023-12-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee2023-12-310001280784Debt Investments Media/Content/Info and Total Fever Labs, Inc.2023-12-310001280784Debt Investments Media/Content/Info (0.69%)2023-12-310001280784Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee2023-12-310001280784Debt Investments Medical Devices & Equipment (1.20%) 2023-12-310001280784Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.70%, Floor rate 10.60%2023-12-310001280784Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.88%, Floor rate 7.78%2023-12-310001280784Debt Investments Software and 3GTMS, LLC2023-12-310001280784Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%2023-12-310001280784Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%2023-12-310001280784Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 6-month SOFR + 7.25%, Floor rate 8.25%2023-12-310001280784Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 9.41%, Floor rate 10.41%2023-12-310001280784Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee2023-12-310001280784Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%2023-12-310001280784Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee2023-12-310001280784Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90%2023-12-310001280784Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.41%, Floor rate 11.81%2023-12-310001280784Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 8.99%, Floor rate 9.89%2023-12-310001280784Debt Investments Software and Constructor Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%2023-12-310001280784Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee2023-12-310001280784Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee2023-12-310001280784Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee2023-12-310001280784Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%2023-12-310001280784Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%2023-12-310001280784Debt Investments Software and Cybermaxx Intermediate Holdings, Inc.2023-12-310001280784Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee2023-12-310001280784Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%2023-12-310001280784Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee2023-12-310001280784Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee2023-12-310001280784Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee2023-12-310001280784Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13%2023-12-310001280784Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%2023-12-310001280784Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.64%, Floor rate 8.54%2023-12-310001280784Debt Investments Software and iGrafx,LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.66%, Floor rate 9.56%2023-12-310001280784Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00%2023-12-310001280784Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50%2023-12-310001280784Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee2023-12-310001280784Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%2023-12-310001280784Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%2023-12-310001280784Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%2023-12-310001280784Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.31%, Floor rate 10.06%2023-12-310001280784Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75%2023-12-310001280784Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%2023-12-310001280784Debt Investments Software and Onna Technologies, Inc., Senior Secured, Maturity Date March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest, 1.75%, 4.45% Exit Fee2023-12-310001280784Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 3-month SOFR + 8.00%, Floor rate 9.00%2023-12-310001280784Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 9.01%, Floor rate 9.91%2023-12-310001280784Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee2023-12-310001280784Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee2023-12-310001280784Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 1-month SOFR + 7.25%, Floor rate 8.25%2023-12-310001280784Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50%2023-12-310001280784Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee2023-12-310001280784Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.25%, Floor rate 10.00%2023-12-310001280784Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee2023-12-310001280784Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%2023-12-310001280784Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%2023-12-310001280784Debt Investments Software (40.39%)2023-12-310001280784Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee2023-12-310001280784Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00%2023-12-310001280784Debt Investments Sustainable and Renewable Technology (0.31%)2023-12-310001280784Debt Investments (169.59%)2023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B2023-12-310001280784Equity Investments Consumer & Business Products and Fabletics, Inc.2023-12-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units2023-12-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Products (0.13%)2023-12-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42023-12-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2023-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-12023-01-012023-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-12023-12-310001280784Equity Investments Consumer & Business Services and Total OfferUp, Inc.2023-12-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C2023-12-310001280784Equity Investments Consumer & Business Services and Total Tectura Corporation2023-12-310001280784Equity Investments Consumer & Business Services (0.70%)2023-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units2023-01-012023-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units2023-12-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2023-01-012023-12-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2023-12-310001280784Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22023-01-012023-12-310001280784Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22023-12-310001280784Equity Investments Diversified Financial Services (3.17%)2023-12-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2023-12-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2023-01-012023-12-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2023-12-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2023-12-310001280784Equity Investments Drug Delivery and Talphera, Inc (p.k.a. AcelRx Pharmaceuticals, Inc. ), Equity, Acquisition Date 12/10/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Drug Delivery and Talphera, Inc (p.k.a. AcelRx Pharmaceuticals, Inc. ), Equity, Acquisition Date 12/10/2018, Series Common Stock2023-12-310001280784Equity Investments Drug Delivery (0.00%)2023-12-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, 5/9/2022, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, 5/9/2022, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, 6/21/2018, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, 6/21/2018, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport), Equity, 4/6/2021, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport), Equity, 4/6/2021, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, 1/8/2015, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, 1/8/2015, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, 7/22/2015, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, 7/22/2015, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, 10/26/2022, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, 10/26/2022, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, 7/25/2015, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, 7/25/2015, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, 5/7/2021, Preferred Series B2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, 5/7/2021, Preferred Series B2023-12-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, 5/3/2022, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, 5/3/2022, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, 3/31/2021, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, 3/31/2021, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, 6/16/2023, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, 6/16/2023, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, 9/29/2023, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, 9/29/2023, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C2023-12-310001280784Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, 8/22/2007, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, 8/22/2007, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, 8/11/2015, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, 8/11/2015, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, 2/2/2017, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, 2/2/2017, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, 5/5/2022, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, 5/5/2022, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, 1/31/2019, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, 1/31/2019, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, 12/11/2020, Preferred Series B2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, 12/11/2020, Preferred Series B2023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC., Equity, 10/31/2022, Preferred Series C2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC., Equity, 10/31/2022, Preferred Series C2023-12-310001280784Equity Investments Drug Discovery & Development and Total Valo Health, LLC2023-12-310001280784Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C2023-12-310001280784Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock2023-01-012023-12-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock2023-12-310001280784Equity Investments Drug Discovery & Development (2.47%)2023-12-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2023-01-012023-12-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2023-12-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2023-12-310001280784Equity Investments Electronics & Computer Hardware (0.05%)2023-12-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2023-01-012023-12-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2023-12-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2023-12-310001280784Equity Investments Healthcare Services, Other (0.05%)2023-12-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2023-01-012023-12-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2023-12-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2023-12-310001280784Equity Investments Information Services (0.35%)2023-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2023-01-012023-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2023-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22023-01-012023-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22023-12-310001280784Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC2023-12-310001280784Equity Investments Medical Devices & Equipment (0.01%)2023-12-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2023-12-310001280784Equity Investments Semiconductors (0.02%)2023-12-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2023-12-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2023-01-012023-12-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2023-12-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32023-01-012023-12-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2023-01-012023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2023-01-012023-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2023-12-310001280784Equity Investments Software, Total Contentful Global, Inc.2023-12-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22023-01-012023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32023-01-012023-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32023-12-310001280784Equity Investments Software, Total Druva Holdings, Inc.2023-12-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2023-12-310001280784Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B22023-01-012023-12-310001280784Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B22023-12-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2023-12-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2023-12-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2023-01-012023-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2023-12-310001280784Equity Investments Software, Total SingleStore, Inc.2023-12-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2023-01-012023-12-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2023-12-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2023-12-310001280784Equity Investments Software (1.27%)2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12023-12-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-12023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-12023-12-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2023-12-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2023-12-310001280784Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock2023-01-012023-12-310001280784Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock2023-12-310001280784Equity Investments Sustainable and Renewable Technology (0.22%)2023-12-310001280784Equity Investments (8.44%)2023-12-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B2023-12-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock2023-12-310001280784Warrant Investments and Biotechnology Tools (0.02%)2023-12-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock2023-12-310001280784Warrant Investments and Communications & Networking (0.01%)2023-12-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C2023-12-310001280784Warrant Investments and Consumer & Business Products (0.02%)2023-12-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D2023-12-310001280784Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Ordinary shares2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Ordinary shares2023-12-310001280784Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B2023-12-310001280784Warrant Investments and Consumer & Business Services and Total Skyword, Inc.2023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A2023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B2023-12-310001280784Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc.2023-12-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D2023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E2023-01-012023-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E2023-12-310001280784Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited2023-12-310001280784Warrant Investments and Consumer & Business Services (0.23%)2023-12-310001280784Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Common Stock2023-12-310001280784Warrant Investments and Diversified Financial Services (0.03%)2023-12-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Common Stock2023-12-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock2023-12-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock2023-12-310001280784Warrant Investments and Drug Delivery (0.00%)2023-12-310001280784Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock2023-12-310001280784 Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units2023-01-012023-12-310001280784 Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units2023-12-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B2023-12-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Ordinary Shares2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Ordinary Shares2023-12-310001280784Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and enGene,Inc, Warrant, Acquisition Date 12/22/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and enGene,Inc, Warrant, Acquisition Date 12/22/2023, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E2023-12-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units2023-12-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Common Stock2023-12-310001280784Warrant Investments and Drug Discovery & Development (0.46%)2023-12-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock2023-01-012023-12-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock2023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock2023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock2023-12-310001280784Warrant Investments and Electronics & Computer Hardware (0.02%)2023-12-310001280784Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Common Stock2023-12-310001280784Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Common Stock2023-12-310001280784Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Common Units2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Common Units2023-12-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock2023-12-310001280784Warrant Investments and Healthcare Services, Other (0.03%)2023-12-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock2023-12-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock2023-12-310001280784Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 12023-01-012023-12-310001280784Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 12023-12-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock2023-12-310001280784Warrant Investments and Information Services (0.03%)2023-12-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2023-12-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock2023-12-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock2023-01-012023-12-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock2023-12-310001280784Warrant Investments and Manufacturing Technology (0.17%)2023-12-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-12023-01-012023-12-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-12023-12-310001280784Warrant Investments and Media/Content/Info (0.01%)2023-12-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-12023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-12023-12-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock2023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock2023-12-310001280784Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Common Stock2023-12-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock2023-01-012023-12-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock2023-12-310001280784Warrant Investments and Medical Devices & Equipment (0.01%)2023-12-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-22023-01-012023-12-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-22023-12-310001280784Warrant Investments and Semiconductors (0.04%)2023-12-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G2023-01-012023-12-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G2023-12-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock2023-12-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock2023-12-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock2023-12-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2023-12-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock2023-12-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B2023-12-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock2023-12-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock2023-12-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock2023-12-310001280784Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock2023-12-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock2023-12-310001280784Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C2023-12-310001280784Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Common Stock2023-12-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock2023-12-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock2023-12-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock2023-12-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B2023-12-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock2023-12-310001280784Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C2023-12-310001280784Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock2023-12-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D2023-12-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2023-12-310001280784Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023 Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Onna Technologies, Inc.Warrant 7/5/2023 Common Stock2023-12-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock2023-12-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock2023-12-310001280784Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock2023-12-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D2023-01-012023-12-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D2023-12-310001280784Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Ordinary Shares2023-01-012023-12-310001280784Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Ordinary Shares2023-12-310001280784Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023 Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023 Common Stock2023-12-310001280784Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA2023-01-012023-12-310001280784Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA2023-12-310001280784Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares2023-01-012023-12-310001280784Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares2023-12-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock2023-12-310001280784Warrant Investments and Software (0.75%)2023-12-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock2023-01-012023-12-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock2023-12-310001280784Warrant Investments and Surgical Devices (0.04%)2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc.2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C2023-01-012023-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C2023-12-310001280784Warrant Investments and Sustainable and Renewable Technology (0.00%)2023-12-310001280784Warrant Investments (1.88%)2023-12-310001280784Investments in Securities (179.92%)2023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202023-01-012023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222023-01-012023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222023-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%)2023-12-310001280784Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222023-01-012023-12-310001280784Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222023-12-310001280784Investment Funds & Vehicles Investments and Software (0.02%)2023-12-310001280784Investment Funds & Vehicles Investments (0.26%)2023-12-310001280784Investments (180.18%)2023-12-310001280784Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, FGTXX/38141W2732023-12-310001280784Investment Fund In Cash & Cash Equivalents (3.11%)2023-12-310001280784Investment Fund After Cash & Cash Equivalents (183.28%)2023-12-310001280784Foreign Currency Exchange Contracts, Great British Pound (GBP) Counterparty Goldman Sachs Bank USA Settlement Date 6/3/20242023-01-012023-12-310001280784Foreign Currency Exchange Contracts, Great British Pound (GBP) Counterparty Goldman Sachs Bank USA Settlement Date 6/3/20242023-12-310001280784Total Foreign Currency Forward ((0.04%))2023-12-310001280784htgc:OneMonthSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-12-310001280784htgc:ThreeMonthSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-12-310001280784htgc:SixMonthSecuredOvernightFinancingRateSOFROvernightIndexSwapRateMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:WarrantMember2023-12-31htgc:Firm0001280784us-gaap:FairValueInputsLevel1Memberus-gaap:CommonStockMember2023-12-310001280784htgc:BlackCrowAIIncMemberhtgc:PromissoryNotesMember2023-12-310001280784htgc:RoyaltyContractMemberhtgc:PhathomPharmaceuticalsIncMember2023-12-310001280784Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee2022-12-310001280784Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee2022-12-310001280784Debt Investments Biotechnology Tools (2.31%)2022-12-310001280784Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee2022-12-310001280784Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31%2022-12-310001280784Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee2022-12-310001280784Debt Investments Communications & Networking (7.26%)2022-12-310001280784Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.8%, 8.29% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50%2022-12-310001280784Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%2022-12-310001280784Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%2022-12-310001280784Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50%2022-12-310001280784Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%2022-12-310001280784Debt Investments Consumer & Business Services, SeatGeek, Inc.2022-12-310001280784Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00%2022-12-310001280784Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25%2022-12-310001280784Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00%2022-12-310001280784Debt Investments Consumer & Business Services, Tectura Corporation2022-12-310001280784Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services, Veem, Inc.2022-12-310001280784Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee2022-12-310001280784Debt Investments Consumer & Business Services (30.59%)2022-12-310001280784Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50%2022-12-310001280784Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50%2022-12-310001280784Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured2022-12-310001280784Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%2022-12-310001280784Debt Investments Diversified Financial Services (2.40%)2022-12-310001280784Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee2022-12-310001280784Debt Investments Drug Discovery & Development (78.59%)2022-12-310001280784Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee2022-12-310001280784Debt Investments Electronics & Computer Hardware (1.34%)2022-12-310001280784Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee2022-12-310001280784Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%2022-12-310001280784Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee2022-12-310001280784Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%2022-12-310001280784Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee2022-12-310001280784Debt Investments Healthcare Services, Other (13.98%)2022-12-310001280784Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee2022-12-310001280784Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee2022-12-310001280784Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08%2022-12-310001280784Debt Investments Information Services (3.72%)2022-12-310001280784Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee2022-12-310001280784Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee2022-12-310001280784Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee2022-12-310001280784Debt Investments Manufacturing Technology (2.99%)2022-12-310001280784Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee2022-12-310001280784Debt Investments Semiconductors (1.51%)2022-12-310001280784Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28%2022-12-310001280784Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57%2022-12-310001280784Debt Investments Software and 3GTMS, LLC2022-12-310001280784Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%2022-12-310001280784Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89%2022-12-310001280784Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00%2022-12-310001280784Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee2022-12-310001280784Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%2022-12-310001280784Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee2022-12-310001280784Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90%2022-12-310001280784Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 3-month SOFR + 8.86%, Floor rate 9.76%2022-12-310001280784Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 9.67%, Floor rate 10.67%2022-12-310001280784Debt Investments Software and CloudBolt Software, Inc., Senior Secured, Maturity Date October 2024, Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee2022-12-310001280784Debt Investments Software and Constructor.io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%2022-12-310001280784Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee2022-12-310001280784Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee2022-12-310001280784Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee2022-12-310001280784Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 9.53%, Floor rate 10.28%2022-12-310001280784Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee2022-12-310001280784Debt Investments Software and Demandbase, Inc., Senior Secured, Maturity Date August 2025, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee2022-12-310001280784Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%2022-12-310001280784Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee2022-12-310001280784Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee2022-12-310001280784Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16%2022-12-310001280784Debt Investments Software and Esentire, Inc., Senior Secured, Maturity Date May 2024, 3-month LIBOR + 9.96%, Floor rate 10.96%2022-12-310001280784Debt Investments Software and Esme Learning Solutions, Inc., Senior Secured, Maturity Date February 2025, Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee2022-12-310001280784Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.79%, Floor rate 8.54%2022-12-310001280784Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.79%, Floor rate 8.70%2022-12-310001280784Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month Eurodollar + 9.00%, Floor rate 10.00%2022-12-310001280784Debt Investments Software and Imperva, Inc., Senior Secured, Maturity Date January 2027, 3-month LIBOR + 7.75%, Floor rate 8.75%2022-12-310001280784Debt Investments Software and Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.), Senior Secured, Maturity Date July 2023, 3-month SOFR + 10.14%, Floor rate 11.14%2022-12-310001280784Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2024, 3-month SOFR + 8.00%, Floor rate 9.00%2022-12-310001280784Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%2022-12-310001280784Debt Investments Software and Logicworks, Senior Secured, Maturity Date January 2024, Prime + 7.50%, Floor rate 10.75%2022-12-310001280784Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month LIBOR + 9.06%, Floor rate 10.06%2022-12-310001280784Debt Investments Software and Nextroll, Inc., Senior Secured, Maturity Date July 2023, Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee2022-12-310001280784Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2025, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee2022-12-310001280784Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%2022-12-310001280784Debt Investments Software and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 6-month SOFR + 7.53%, Floor rate 8.53%2022-12-310001280784Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.00%, Floor rate 9.00%2022-12-310001280784Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 9.00%, Floor rate 10.00%2022-12-310001280784Debt Investments Software and Tact.ai Technologies, Inc., Senior Secured, Maturity Date February 2024, Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee2022-12-310001280784Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month LIBOR + 9.00%, Floor rate 10.00%2022-12-310001280784Debt Investments Software and VideoAmp, Inc., Senior Secured, Maturity Date February 2025, Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee2022-12-310001280784Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%2022-12-310001280784Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%2022-12-310001280784Debt Investments Software (54.28%)2022-12-310001280784Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee2022-12-310001280784Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date December 2024, PIK Interest 10.00%2022-12-310001280784Debt Investments Sustainable and Renewable Technology (0.50%)2022-12-310001280784Debt Investments (199.47%)2022-12-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units2022-01-012022-12-310001280784Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units2022-12-310001280784Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Products (0.04%)2022-12-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-42022-12-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A2022-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-12022-01-012022-12-310001280784Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-12022-12-310001280784Equity Investments Consumer & Business Services and Total OfferUp, Inc.2022-12-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-22022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-22022-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB2022-12-310001280784Equity Investments Consumer & Business Services and Total Tectura Corporation2022-12-310001280784Equity Investments Consumer & Business Services and Uber Technologies, Inc., Equity, Acquisition Date 12/1/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Consumer & Business Services and Uber Technologies, Inc., Equity, Acquisition Date 12/1/2020, Series Common Stock2022-12-310001280784Equity Investments Consumer & Business Services (0.57%)2022-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock2022-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A2022-01-012022-12-310001280784Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A2022-12-310001280784Equity Investments Diversified Financial Services, Gibraltar Business Capital, LLC2022-12-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2022-01-012022-12-310001280784Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units2022-12-310001280784Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22022-01-012022-12-310001280784Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-22022-12-310001280784Equity Investments Diversified Financial Services (2.49%)2022-12-310001280784Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock2022-12-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock2022-12-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2022-01-012022-12-310001280784Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D2022-12-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock2022-12-310001280784Equity Investments Drug Delivery (0.01%)2022-12-310001280784Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock2022-12-310001280784Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B2022-12-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C2022-12-310001280784Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B2022-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C2022-12-310001280784Equity Investments Drug Discovery & Development, Valo Health LLC2022-12-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock2022-01-012022-12-310001280784Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock2022-12-310001280784Equity Investments Drug Discovery & Development (2.66%)2022-12-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2022-01-012022-12-310001280784Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F2022-12-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2022-01-012022-12-310001280784Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E2022-12-310001280784Equity Investments Electronics & Computer Hardware (0.11%)2022-12-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2022-01-012022-12-310001280784Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock2022-12-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2022-01-012022-12-310001280784Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C2022-12-310001280784Equity Investments Healthcare Services, Other (0.21%)2022-12-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2022-01-012022-12-310001280784Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock2022-12-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2022-01-012022-12-310001280784Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E2022-12-310001280784Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock2022-01-012022-12-310001280784Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock2022-12-310001280784Equity Investments Information Services (0.58%)2022-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2022-01-012022-12-310001280784Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units2022-12-310001280784Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22022-01-012022-12-310001280784Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-22022-12-310001280784Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC2022-12-310001280784Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA2022-01-012022-12-310001280784Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA2022-12-310001280784Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock2022-01-012022-12-310001280784Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock2022-12-310001280784Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock2022-01-012022-12-310001280784Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock2022-12-310001280784Equity Investments Medical Devices & Equipment (0.07%)2022-12-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2022-01-012022-12-310001280784Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C2022-12-310001280784Equity Investments Semiconductors (0.01%)2022-12-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock2022-12-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2022-01-012022-12-310001280784Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note2022-12-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32022-01-012022-12-310001280784Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-32022-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2022-01-012022-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C2022-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2022-01-012022-12-310001280784Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D2022-12-310001280784Equity Investments Software, Contentful Global, Inc.2022-12-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock2022-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22022-01-012022-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 22022-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32022-01-012022-12-310001280784Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 32022-12-310001280784Equity Investments Software, Druva Holdings, Inc.2022-12-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock2022-12-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock2022-12-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock2022-12-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock2022-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2022-01-012022-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E2022-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2022-01-012022-12-310001280784Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F2022-12-310001280784Equity Investments Software, SingleStore, Inc.2022-12-310001280784Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock2022-12-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2022-01-012022-12-310001280784Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E2022-12-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock2022-12-310001280784Equity Investments Software (2.07%)2022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B2022-01-012022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B2022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C2022-01-012022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C2022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D2022-01-012022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D2022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E2022-01-012022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E2022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F2022-01-012022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F2022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-12022-01-012022-12-310001280784Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-12022-12-310001280784Equity Investments Surgical Devices, Gynesonics, Inc.2022-12-310001280784Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock2022-01-012022-12-310001280784Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock2022-12-310001280784Equity Investments Surgical Devices (0.18%)2022-12-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-12022-12-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-12022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-12022-12-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock2022-12-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units2022-12-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock2022-12-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D2022-12-310001280784Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock2022-01-012022-12-310001280784Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock2022-12-310001280784Equity Investments Sustainable and Renewable Technology (0.57%)2022-12-310001280784Equity Investments (9.56%)2022-12-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B2022-12-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock2022-12-310001280784Warrant Investments and Biotechnology Tools (0.03%)2022-12-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock2022-12-310001280784Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock2022-01-012022-12-310001280784Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock2022-12-310001280784Warrant Investments and Communications & Networking (0.01%)2022-12-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units2022-12-310001280784Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B2022-12-310001280784Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C2022-12-310001280784Warrant Investments and Consumer & Business Products (0.17%)2022-12-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D2022-12-310001280784Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B2022-12-310001280784Warrant Investments and Consumer & Business Services and Skyword, Inc.2022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A2022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B2022-12-310001280784Warrant Investments and Consumer & Business Services and Snagajob.com, Inc.2022-12-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2022-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D2022-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E2022-01-012022-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E2022-12-310001280784Warrant Investments and Consumer & Business Services and Worldremit Group Limited2022-12-310001280784Warrant Investments and Consumer & Business Services (0.19%)2022-12-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock2022-12-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock2022-12-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock2022-12-310001280784Warrant Investments and Drug Delivery (0.00%)2022-12-310001280784Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units2022-12-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B2022-12-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 32022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 32022-12-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E2022-12-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units2022-12-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock2022-12-310001280784Warrant Investments and Drug Discovery & Development (0.60%)2022-12-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock2022-01-012022-12-310001280784Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock2022-12-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock2022-12-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock2022-12-310001280784Warrant Investments and Electronics & Computer Hardware (0.09%)2022-12-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock2022-12-310001280784Warrant Investments and Healthcare Services, Other (0.00%)2022-12-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock2022-12-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock2022-12-310001280784Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 12022-01-012022-12-310001280784Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 12022-12-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock2022-12-310001280784Warrant Investments and Information Services (0.04%)2022-12-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock2022-12-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock2022-12-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock2022-01-012022-12-310001280784Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock2022-12-310001280784Warrant Investments and Manufacturing Technology (0.30%)2022-12-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-12022-01-012022-12-310001280784Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-12022-12-310001280784Warrant Investments and Media/Content/Info (0.00%)2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock2022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA2022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB2022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-12022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-12022-12-310001280784Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock2022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock2022-12-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock2022-01-012022-12-310001280784Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock2022-12-310001280784Warrant Investments and Medical Devices & Equipment (0.07%)2022-12-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-22022-01-012022-12-310001280784Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-22022-12-310001280784Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock2022-12-310001280784Warrant Investments and Semiconductors (0.04%)2022-12-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G2022-01-012022-12-310001280784Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G2022-12-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock2022-12-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock2022-12-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2022-12-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock2022-12-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B2022-12-310001280784Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock2022-12-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock2022-12-310001280784Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock2022-12-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock2022-12-310001280784Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C2022-01-012022-12-310001280784Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C2022-12-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock2022-12-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B2022-12-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock2022-12-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D2022-01-012022-12-310001280784Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D2022-12-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock2022-12-310001280784Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock2022-12-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock2022-12-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock2022-12-310001280784Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred2022-01-012022-12-310001280784Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred2022-12-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D2022-01-012022-12-310001280784Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D2022-12-310001280784Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock2022-12-310001280784Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA2022-01-012022-12-310001280784Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA2022-12-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock2022-12-310001280784Warrant Investments and Software (0.59%)2022-12-310001280784Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C2022-01-012022-12-310001280784Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C2022-12-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock2022-01-012022-12-310001280784Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock2022-12-310001280784Warrant Investments and Surgical Devices (0.04%)2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock2022-01-012022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-12022-01-012022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-12022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A2022-01-012022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B2022-01-012022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Halio, Inc.2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D2022-01-012022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C2022-01-012022-12-310001280784Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C2022-12-310001280784Warrant Investments and Sustainable and Renewable Technology (0.03%)2022-12-310001280784Warrant Investments (2.19%)2022-12-310001280784Investments in Securities (211.21%)2022-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202022-01-012022-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/20202022-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222022-01-012022-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/20222022-12-310001280784Investment Funds & Vehicles Investments and Drug Discovery & Development (0.25%)2022-12-310001280784Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222022-01-012022-12-310001280784Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/20222022-12-310001280784Investment Funds & Vehicles Investments and Software (0.03%)2022-12-310001280784Investment Funds & Vehicles Investments (0.28%)2022-12-310001280784Investments (211.49%)2022-12-310001280784htgc:PRIMEInterestRateMember2022-12-310001280784htgc:OneMonthLIBORMember2022-12-310001280784htgc:ThreeMonthLIBORMember2022-12-310001280784htgc:SixMonthLIBORMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:WarrantMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:CommonStockMember2022-12-310001280784htgc:BlackCrowAIIncMemberhtgc:PromissoryNotesMember2022-12-310001280784htgc:RoyaltyContractMemberhtgc:PhathomPharmaceuticalsIncMember2022-12-310001280784us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowAndOtherInvestmentReceivableMember2023-12-310001280784htgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:PrivateEquityFundsForeignMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784htgc:ExcludingCashAndCashEquivalentMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784htgc:DerivativeInstrumentMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784htgc:IncludingCashAndCashEquivalentsAndDerivativeInstrumentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:EscrowReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784htgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:PrivateEquityFundsForeignMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784htgc:ExcludingCashAndCashEquivalentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784htgc:HtgcDebtAndEquitySecuritiesRealizedGainLossMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:EscrowAndOtherInvestmentReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-12-310001280784htgc:HtgcDebtAndEquitySecuritiesRealizedGainLossMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SeniorSecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberhtgc:EscrowReceivableMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:PreferredStockInvestmentMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:PreferredStockInvestmentMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:CommonStockInvestmentMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:CommonStockInvestmentMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:WarrantInvestmentMember2023-01-012023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:WarrantInvestmentMember2022-01-012022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMemberhtgc:ValuationTechniqueLiquidationMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:TechnologyMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:SustainableAndRenewableTechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CostApproachValuationTechniqueMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsImminentPayoffsMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtMaturingWithinOneYearMemberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:OtherInvestmentReceivableMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:OtherInvestmentReceivablesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:OtherInvestmentReceivableMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:OtherInvestmentReceivablesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:OtherInvestmentReceivableMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMemberhtgc:OtherInvestmentReceivablesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:OtherInvestmentReceivableMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:OtherInvestmentReceivablesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsAndOtherInvestmentReceivablesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:PharmaceuticalsMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:TechnologyMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberus-gaap:IncomeApproachValuationTechniqueMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMemberhtgc:TechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:SustainableAndRenewableTechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:DebtInvestmentsMemberhtgc:SustainableAndRenewableTechnologyMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MaximumMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputHypotheticalMarketYieldMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberhtgc:MeasurementInputPremiumDiscountNettingMembersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMembersrt:MinimumMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberhtgc:LowerMiddleMarketMemberhtgc:DebtInvestmentsMemberhtgc:MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:CostApproachValuationTechniqueMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsImminentPayoffsMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtMaturingWithinOneYearMemberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:DebtInvestmentsMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:MinimumMemberus-gaap:MeasurementInputEbitdaMultipleMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:WeightedAverageMemberus-gaap:MeasurementInputEbitdaMultipleMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:WeightedAverageMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputTangibleBookValueMultipleMemberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputTangibleBookValueMultipleMemberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputTangibleBookValueMultipleMemberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:WeightedAverageMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:WeightedAverageMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:ValuationTechniqueOptionPricingModelMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMembersrt:WeightedAverageMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:ValuationTechniqueOtherMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:WarrantMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:WarrantMembersrt:MinimumMemberus-gaap:MeasurementInputEbitdaMultipleMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:WarrantMemberus-gaap:MeasurementInputEbitdaMultipleMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:MeasurementInputEbitdaMultipleMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:WeightedAverageMemberus-gaap:WarrantMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:WarrantMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:WarrantMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:WeightedAverageMemberus-gaap:WarrantMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberhtgc:ValuationTechniqueOtherMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:EquityAndWarrantInvestmentsMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:MinimumMemberus-gaap:MeasurementInputEbitdaMultipleMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:WeightedAverageMemberus-gaap:MeasurementInputEbitdaMultipleMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:WeightedAverageMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputTangibleBookValueMultipleMemberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputTangibleBookValueMultipleMemberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputTangibleBookValueMultipleMemberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMembersrt:WeightedAverageMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:WeightedAverageMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:ValuationTechniqueOptionPricingModelMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:EquitySecuritiesMembersrt:WeightedAverageMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:MinimumMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:WeightedAverageMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:MinimumMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:WeightedAverageMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberhtgc:ValuationTechniqueOtherMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:WarrantMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:WarrantMembersrt:MinimumMemberus-gaap:MeasurementInputEbitdaMultipleMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:WarrantMemberus-gaap:MeasurementInputEbitdaMultipleMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:MeasurementInputEbitdaMultipleMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputRevenueMultipleMembersrt:WeightedAverageMemberus-gaap:WarrantMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:WarrantMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:WarrantMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:ValuationTechniqueMarketComparableCompaniesMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:WeightedAverageMemberus-gaap:WarrantMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MinimumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputMarketEquityAdjustmentMemberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MeasurementInputMarketEquityAdjustmentMembersrt:WeightedAverageMemberus-gaap:WarrantMemberus-gaap:ValuationTechniqueOptionPricingModelMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMembersrt:MinimumMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:WarrantMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRevenueMultipleMembersrt:WeightedAverageMemberus-gaap:WarrantMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:WarrantMembersrt:MinimumMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMemberus-gaap:WarrantMemberhtgc:ValuationTechniqueLiquidationMembersrt:MaximumMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMembersrt:WeightedAverageMemberus-gaap:WarrantMemberhtgc:ValuationTechniqueLiquidationMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberhtgc:ValuationTechniqueOtherMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:EquityAndWarrantInvestmentsMember2022-12-310001280784htgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784htgc:TwoThousandThirtyThreeNotesMember2022-12-310001280784htgc:TwoThousandThirtyThreeNotesMemberhtgc:UnderwritingMember2023-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SBADebenturesMember2023-12-310001280784htgc:SBADebenturesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:SBADebenturesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:SBADebenturesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SBADebenturesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JulyTwoThousandTwentyFourNotesMember2023-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2023-12-310001280784htgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveNotesMember2023-12-310001280784htgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberhtgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberhtgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixANotesMember2023-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixBNotesMember2023-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMember2023-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2023-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MUFGBankFacilityMember2023-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SMBCFacilityMember2023-12-310001280784htgc:SMBCFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:SMBCFacilityMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784htgc:SMBCFacilityMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SMBCFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SBADebenturesMember2022-12-310001280784htgc:SBADebenturesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:SBADebenturesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:SBADebenturesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:SBADebenturesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JulyTwoThousandTwentyFourNotesMember2022-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:JulyTwoThousandTwentyFourNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:FebruaryTwoThousandTwentyFiveNotesMember2022-12-310001280784htgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel2Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:FebruaryTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveNotesMember2022-12-310001280784htgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberhtgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel2Memberhtgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:JuneTwoThousandTwentyFiveNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2022-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:JuneTwoThousandTwentyFiveThreeYearNotesMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixANotesMember2022-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:MarchTwoThousandTwentySixANotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MarchTwoThousandTwentySixANotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MarchTwoThousandTwentySixBNotesMember2022-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MarchTwoThousandTwentySixBNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2022-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:SeptemberTwoThousandTwentySixNotesMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:JanuaryTwoThousandTwentySevenNotesMember2022-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:JanuaryTwoThousandTwentySevenNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyOneAssetBackedNotesMember2022-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:TwoThousandThirtyOneAssetBackedNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2022-12-310001280784us-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberhtgc:TwoThousandThirtyThreeNotesMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:MUFGBankFacilityMember2022-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:MUFGBankFacilityMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:FairValueInputsLevel3Memberhtgc:MUFGBankFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784us-gaap:CarryingReportedAmountFairValueDisclosureMemberhtgc:SMBCFacilityMember2022-12-310001280784htgc:SMBCFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001280784htgc:SMBCFacilityMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-31